Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3664276 | 1.00 | ALDH1A1 (0.32) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL1158205 | 1.00 | ALDH1A1 (0.32) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL20420849 | 0.87 | — | — | |
| SCHEMBL4541470 | 0.82 | ALDH1A1 (0.33) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL4541471 | 0.82 | ALDH1A1 (0.33) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL2358767 | 0.80 | ALDH1A1 (0.32) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL2358765 | 0.80 | ALDH1A1 (0.32) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL1023965 | 0.78 | ALDH1A1 (0.31) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL8752967 | 0.78 | ALDH1A1 (0.31) | ALDH1A1PTGS1SLC7A11 | |
| SCHEMBL1023964 | 0.78 | ALDH1A1 (0.31) | ALDH1A1PTGS1SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112155208-A | Application of garlic organic sulfide in preparing liver-protecting food, health-care product or medicine | 湖南农业大学 | 2021-01-01 | — | — | CN | disclosed |
| US-20140127179-A1 | Natural Killer Cell Formulations | SCIENTIFIC FORMULATIONS, LLC (US) | 2014-05-08 | — | — | US | disclosed |
| US-8623919-B2 | Method of synthesizing S-allyl-cysteine analogues and their therapeutic application in treating myocardial infarction | FUDAN UNIVERSITY (CN) | 2014-01-07 | — | — | US | disclosed |
| US-20090036534-A1 | Method Of Synthesizing S-Allyl-Cysteine Analogues And Their Therapeutic Application In Treating Myocardial Infarction | FUDAN UNIVERSITY (CN) | 2009-02-05 | — | — | US | disclosed |
| WO-2004089108-A1 | FOOD SUPPLEMENT FOR ANIMALS, ESPECIALLY POULTRY | PHYTOSYNTHESE (FR) | 2004-10-21 | — | — | WO | disclosed |
| EP-0180672-B1 | PROCESS FOR THE PRODUCTION OF FLAVOR ENHANCING SEASONINGS | AJINOMOTO CO., INC. (JP) | 1988-09-21 | — | — | EP | disclosed |
| US-4741914-A | WITH GLUTAMIC ACID SALT | AJINOMOTO CO., INC. (JP) | 1988-05-03 | — | — | US | disclosed |
| EP-0180672-A1 | Process for the production of flavor enhancing seasonings | AJINOMOTO CO., INC. (JP) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036534-A1 | Method Of Synthesizing S-Allyl-Cysteine Analogues And Their Therapeutic Application In Treating Myocardial Infarction | SRM, SMS, SCLY | ALDH1A1 1122/4885PTGS1 1212/4885SLC7A11 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.